Traders Buy Anheuser-Busch Inbev SA (BUD) on Weakness

Lloyd Doyle
October 21, 2017

Institutional investors own 5.50% of the company's stock. Vantage Invest Advsr Limited Co reported 492 shares. The company has market cap of $211.25 billion. Volume was down 96.95% under the stocks average daily volume.

About 554,165 shares traded. InnerWorkings, Inc. (NASDAQ:INWK) has risen 36.17% since October 19, 2016 and is uptrending. It has underperformed by 31.89% the S&P500. Johnson Financial Group Inc. now owns 1,179 shares of the consumer goods maker's stock valued at $130,000 after purchasing an additional 3 shares during the period. Campbell And Investment Adviser reported 16,730 shares stake.

Shares of Anheuser-Busch Inbev SA (BUD) traded down 0.282% during mid-day trading on Friday, hitting $125.585. It is down 0.00% since October 19, 2016 and is. It has underperformed by 20.25% the S&P500. Advsrs Capital Mgmt Limited Liability Company invested 0.32% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Therefore 64% are positive. Of all companies tracked, Anheuser-Busch Inbev SA had the 21st highest net in-flow for the day. The firm earned "Buy" rating on Friday, July 28 by Jefferies. As per Friday, February 26, the company rating was maintained by Stifel Nicolaus. Vetr upgraded the shares of BUD in report on Thursday, August 13 to "Buy" rating. Finally, Jefferies Group LLC set a $139.00 price target on Anheuser-Busch Inbev SA and gave the company a "buy" rating in a research note on Saturday, July 29th. On Tuesday, September 8 the stock rating was maintained by RBC Capital Markets with "Outperform". The company was initiated on Monday, October 3 by Liberum Capital. As per Wednesday, September 30, the company rating was initiated by UBS.

Traders bought shares of Anheuser-Busch Inbev SA (NYSE:BUD) on weakness during trading hours on Wednesday. Mufg Americas Hldgs stated it has 0.02% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD).

Investors sentiment decreased to 0.98 in 2017 Q2. Its last month's stock price volatility remained 0.85% which for the week stands at 1.12%. It dived, as 33 investors sold BUD shares while 166 reduced holdings. 48 funds opened positions while 146 raised stakes. 863,626 shares of the stock were exchanged. Mawer Inv Management has 0.08% invested in Anheuser Busch Inbev NV (ADR) (NYSE:BUD) for 78,633 shares. American Asset, a Florida-based fund reported 3,527 shares.

On September 8, 2017 Argus added the stock to its research portfolio with a rating of "Buy". BDO Wealth Advisors LLC acquired a new stake in shares of Anheuser-Busch Inbev SA during the second quarter valued at approximately $110,000. Norris Perne & French Ltd Liability Partnership Mi reported 0.71% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Peak6 Investments Lp holds 0.12% or 190,969 shares. Richard C Young & Communications holds 1.51% or 70,031 shares. Neuberger Berman Gp Llc invested in 137,158 shares or 0.02% of the stock. Jacobus Wealth Management Inc. now owns 1,042 shares of the consumer goods maker's stock valued at $114,000 after acquiring an additional 42 shares during the period.

Among 22 analysts covering Anheuser-Busch InBev (NYSE:BUD), 14 have Buy rating, 1 Sell and 7 Hold. Glenmede Tru Na holds 22,234 shares or 0.01% of its portfolio. Etrade Limited Co has invested 0.05% in QUALCOMM, Inc. Sterne Agee CRT initiated Anheuser Busch Inbev NV (ADR) (NYSE:BUD) on Tuesday, July 21 with "Buy" rating.

Analysts await ACADIA Pharmaceuticals Inc. They expect $-0.63 EPS, down 3.28% or $0.02 from last year's $-0.61 per share. (NASDAQ:QCOM), 13 have Buy rating, 1 Sell and 21 Hold. Therefore 100% are positive. 7,805 were reported by Tci Wealth Advsr. (NASDAQ:INWK) earned "Outperform" rating by Barrington Research on Monday, February 27. Needham maintained ACADIA Pharmaceuticals Inc. The rating was upgraded by Berenberg to "Buy" on Friday, November 13. Needham has "Buy" rating and $49 target. The stock of ACADIA Pharmaceuticals Inc. The company saw a fall in short interest of -4.55% as of the latest report on September 29, 2017. Morgan Stanley has 4.78 million shares. Goldman Sachs Group, Inc. The company was downgraded on Thursday, October 20 by Societe Generale. H.C. Wainwright has "Buy" rating and $60.0 target. The firm earned "Neutral" rating on Thursday, August 27 by Piper Jaffray.

More important recent ACADIA Pharmaceuticals Inc.

Fdx Advisors Inc decreased General Electric Co Com (NYSE:GE) stake by 63,104 shares to 432,851 valued at $11.69M in 2017Q2.

Other reports by Iphone Fresh

Discuss This Article